LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.540
-0.010 (-0.65%)
Oct 13, 2025, 4:00 PM EDT - Market closed
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $40.51 million as of October 13, 2025. Its market cap has decreased by -6.07% in one year.
Market Cap
40.51M
Enterprise Value
-15.40M
1-Year Change
-6.07%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $40.51M, a decrease of -89.35%. That is a compound annual growth rate of -38.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 40.77M | 63.03% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
| Mar 25, 2021 | 380.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |